| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 652.00K | -74.92% |
| Operating expense | — | — |
| Net income | -12.04M | -14.03% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GSGTF returned -52.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -52.7% |
| 1 year | -52.7% |
| 5 years | -99.0% |
| All-time high | $10.85 (Apr 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GSGTF would be worth today ›No. GenSight Biologics S.A. has not paid a dividend in the past 12 months.
GenSight Biologics S.A. is part of the Healthcare sector.
GenSight Biologics S.A. has a market cap of 21.10M USD, based on the latest quote.
